These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
68 related articles for article (PubMed ID: 210537)
1. [Immunogenic study of killed influenza vaccine purified and concentrated by a chromatographic method on silicate sorbents. I. The immunogenic properties of a vaccine from the A/Victoria/72 strain]. Malafeeva LK; Fridman EA; Zheleznova NV; Polzik TP; Ivanov KG Tr Inst Im Pastera; 1976; 47():124-8. PubMed ID: 210537 [No Abstract] [Full Text] [Related]
2. [Immunogenic study of killed influenza vaccine purified and concentrated by a chromatographic method on silica sorbents. II. The immunogenic properties of a vaccine from the A/Scotland/74 strain]. Polzik TP; Bichurina MA; Goriunova VV; Bokhnevich GM; Polianskaia NIu Tr Inst Im Pastera; 1976; 47():128-33. PubMed ID: 210538 [No Abstract] [Full Text] [Related]
3. [Secretory immunity in persons inoculated with killed influenza vaccine purified and concentrated on silicate sorbents]. Bichurina MA Tr Inst Im Pastera; 1976; 47():134-40. PubMed ID: 210539 [No Abstract] [Full Text] [Related]
4. [Characteristics of the chromatographic purification of influenza viruses on porous silicate sorbents]. Molodkin VM; Mchedlishvili BV; Katushkina NV; Zheleznova NV; Polianskaia NIu Tr Inst Im Pastera; 1976; 47():34-8. PubMed ID: 210541 [No Abstract] [Full Text] [Related]
5. [Control of killed influenza vaccine purified and concentrated on silicate sorbents]. Medvedkova AA; Karpovich NM Tr Inst Im Pastera; 1976; 47():54-5. PubMed ID: 210542 [No Abstract] [Full Text] [Related]
6. [Acute respiratory infection morbidity after the use of killed influenza A/Victoria/72 vaccine]. Ivanov KG; Beliakov VD; Ishkil'din MI; Maliarenko IuD Tr Inst Im Pastera; 1976; 47():146-50. PubMed ID: 802565 [No Abstract] [Full Text] [Related]
7. [Evaluation data from experimental series on a killed influenza vaccine purified and concentrated by differential and density gradient centrifugation. II. The results of a study of the reactogenic properties of the vaccine]. Karpukhin GI; Popov IV; Malikova EV Tr Inst Im Pastera; 1976; 47():156-9. PubMed ID: 802567 [No Abstract] [Full Text] [Related]
8. [Further study of the reactogenic properties and safety of a killed influenza A/Scotland/74 vaccine]. Ranevskiĭ VD; Belov AB; Ivanov KG; Ishkil'din MI; Markelov IM Tr Inst Im Pastera; 1976; 47():121-3. PubMed ID: 802564 [No Abstract] [Full Text] [Related]
9. [Properties and biological activity of inactivated influenza vaccine]. D'iachenko AP Mikrobiol Zh (1978); 1982; 44(3):57-9. PubMed ID: 7121321 [No Abstract] [Full Text] [Related]
10. [Reactogenic properties and the immunological activity of an absorbed influenza chemical vaccine]. Rudenko LG; Ishkil'din MI; Esorov PA; Ranevskiĭ VD; Zoshchenkova PIa Tr Inst Im Pastera; 1976; 47():160-3. PubMed ID: 802568 [No Abstract] [Full Text] [Related]
11. [Patterns of change in the immunity of those inoculated with an inactivated chromatographic influenza vaccine on an annual basis]. Mukhina LP; Bichurina MA; Rozaeva NR Tr Inst Im Pastera; 1983; 61():151-5. PubMed ID: 6678508 [No Abstract] [Full Text] [Related]
12. [Characteristics of the reactogenic and immunogenic properties of killed influence vaccine purified and concentrated by the method of adsorbed chromatography on silicate sorbents]. Peradze TV; Fridman EA; Kolikov VM; Bichurina MA; Goriunova VV Zh Mikrobiol Epidemiol Immunobiol; 1976 Sep; (9):18-22. PubMed ID: 1015075 [TBL] [Abstract][Full Text] [Related]
13. Further researches on live influenza virus vaccines. De Barbieri A; Crovari P; Cuneo-Crovari P; Giacometti G Dev Biol Stand; 1977 Jun 1-3; 39():73-6. PubMed ID: 604136 [TBL] [Abstract][Full Text] [Related]
14. Clinico-immunologic and allergologic studies with the inactivated influenza virus vaccine purified and concentrated by gradient centrifugation. Subbotina TI; Tenkova TV; Sidorova LV; Shpilyuk GF; Drinevsky VP; Voitsekhovskaya EM; Konstantinov VK; Sominina AA Acta Virol; 1988 Nov; 32(6):494-502. PubMed ID: 2906221 [TBL] [Abstract][Full Text] [Related]
15. Reactogenicity to primary and repeated vaccination with influenza split virus vaccine. Hennessen W; Mauler R; Gruschkau H; Lehmann HG Dev Biol Stand; 1977 Jun 1-3; 39():289-93. PubMed ID: 604110 [TBL] [Abstract][Full Text] [Related]
16. A placebo-controlled dose-response study of the reactogenicity and immunogenicity of a cold-adapted recombinant A/Victoria/3/75 (H3N2) live influenza virus candidate vaccine in healthy volunteers. Hrabar A; Vodopija I; André FE; Mitchell JR; Maassab HF; Hennessy AV; Davenport FM Dev Biol Stand; 1977 Jun 1-3; 39():53-60. PubMed ID: 342317 [No Abstract] [Full Text] [Related]
17. Potentiation of the immune response to influenza virus subunit vaccines. Webster RG; Glezen WP; Kasel JA; Laver WG Dev Biol Stand; 1977 Jun 1-3; 39():243-8. PubMed ID: 604104 [TBL] [Abstract][Full Text] [Related]
18. [Secretory and serum response after intranasal influenza vaccination with A/Victoria attenuated live virus]. Crifò S; Filiaci F; Pelosio A; Rocchi G Boll Soc Ital Biol Sper; 1978 Jun; 54(11):1021-6. PubMed ID: 743410 [No Abstract] [Full Text] [Related]
19. Subunit influenza vaccine and its testing in clinical immunology. Zykov MP; Rudenko LG; Zoshchenkova NY; Rafael'skaya TI J Hyg Epidemiol Microbiol Immunol; 1980; 24(2):212-8. PubMed ID: 6997374 [TBL] [Abstract][Full Text] [Related]
20. Immunization against influenza A virus: comparison of conventional inactivated, live-attenuated and recombinant baculovirus produced purified hemagglutinin and neuraminidase vaccines in a murine model system. Brett IC; Johansson BE Virology; 2005 Sep; 339(2):273-80. PubMed ID: 15996702 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]